Catalyst
Slingshot members are tracking this event:
Celyad(CYAD) initiates Phase 1 SHRINK and LINK trials of CYAD-01 in colorectal cancer patients diagnosed with unresectable liver metastases
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CYAD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2018
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Shrink, Link, Cyad-01, Colorectal Cancer
